Molecular tumor board availability and organization in sarcoma referral centers in Italy: are we on the right track? - Takeaways - MDSpire

Molecular tumor board availability and organization in sarcoma referral centers in Italy: are we on the right track?

  • By

  • Concetta Elisa Onesti

  • Beatrice Casini

  • Annarosaria De Chiara

  • Valentina Fausti

  • Roberto Luksch

  • Giuseppe Maria Milano

  • Emanuela Palmerini

  • Sabrina Vari

  • Serena Ceddia

  • Federica Riva

  • Toni Ibrahim

  • Renato Covello

  • Gennaro Ciliberto

  • Katia Scotlandi

  • Virginia Ferraresi

  • June 3, 2026

  • 0 min

Share

  • 1

    Molecular tumor boards (MTBs) are established in most Italian sarcoma treatment centers, facilitating individualized treatment options.

  • 2

    The survey revealed that 83% of centers have a dedicated oncologist present during MTB discussions, ensuring case evaluation.

  • 3

    All centers reported using target panel sequencing and whole exome sequencing, with 83% also utilizing whole genome sequencing.

  • 4

    The analysis turnaround time varied, with 33% of centers providing results in 10 days or less, while 67% took longer.

  • 5

    The findings underscore the need for standardized MTB practices to enhance the treatment of rare cancers like sarcomas in Italy.

Original Source(s)

Related Content